Podcasts about aasm

Nobody blinks when a doctor says you'll be on blood pressure medication for the rest of your life. Say the same sentence about an antidepressant, or Zepbound, and responses are quite different. This episode digs into deprescribing, the fast-growing clinical movement around when and how to stop medications, and asks why some "forever drugs" get a cultural pass while others get moralized. In this episode we will:Separate the real clinical debate around antidepressant tapering from the online discourseTake on the GLP-1 stigma directly, with two 2024 JAMA Internal Medicine studies that found no elevated depression or suicidality risk, and ask why "you may need this forever" reads as scandal here but shrug everywhere elseSit with the RLS story, where the science just ran the opposite direction: 2025 AASM guidelines downgraded dopamine agonists after mounting evidence of augmentation, a drug-induced worsening of symptoms, making deprescribing here the conservative, evidence-driven move, not the fringe oneAsk why hypersomnia drugs generate almost zero cultural friction at all, and what that quiet exception reveals about the other threeLand on what actually predicts whether a "forever medication" gets treated as a fact of chronic disease or a personal failing — and why RLS should make you distrust any tidy answer to that question, including this episode'sTo find out more about this week's podcast sponsor Fitnexa and their SomniPods 3, please use the following link https://go.fitnexa.com/egVvZ9 and use the code DRCHRIS10 for $10 dollars off your order.Original intro music Vigilanteology by Abhinav Singh (copyright 2026) Original outro music Vigilanteology (reprise) by Abhinav Singh (copyright 2026)Produced by: Maeve WinterMusic by: Dr. Abhinav Singh (@sleep_vigilante), all rights reservedMoreTwitter: @drchriswinterIG: @drchriwinterThreads: @drchriswinterBluesky: @drchriswinterThe Sleep Solution and The Rested ChildThanks for listening and sleep well!

In this episode of Talking Sleep, host Dr. Seema Khosla welcomes Dr. Karin Johnson, Professor of Neurology at UMass Chan School of Medicine–Baystate and expert on circadian rhythm policy, to discuss two competing legislative bills addressing permanent time change in the United States. Two bills currently before Congress present starkly different solutions: the Sunshine Protection Act for permanent daylight saving time and the Sunshine for Our Kids Act for permanent standard time. Both campaigns use compelling language that makes their position sound obvious, complicating decisions for policymakers and clinicians alike. Dr. Johnson reviews the AASM's official position on daylight saving time and what research reveals about time change effects—both short-term consequences of bi-annual clock transitions and long-term health impacts of permanent DST, particularly on adolescent mental health and circadian rhythm disruption. She explains what happened during the 1974 experiment with year-round daylight saving time and why that experience remains relevant today. The conversation details both the Sunshine Protection Act and the Sunshine for Our Kids Act, including their legislative progress and specific provisions. Dr. Johnson clarifies which approach sleep medicine clinicians support and provides practical guidance on advocacy. An intriguing discussion explores a proposed compromise to move clocks by 30 minutes and leave them there—why didn't this gain traction? Dr. Johnson also reveals how industry influence shapes policy, discussing candy companies' historical support for daylight saving time and other commercial interests that complicate what should be a health-based decision. Dr. Johnson emphasizes that permanent standard time better aligns with human circadian biology, particularly for adolescents whose naturally delayed circadian rhythms suffer under permanent DST. Whether you're seeking to understand these competing bills, advocate for science-based policy, or interested in how medical evidence influences legislation, this episode provides clarity on a complex issue with direct health implications. Join us for this important conversation about how sleep medicine can influence public health policy.

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this Mind Moments episode, Todd Arnedt, PhD, professor of psychiatry and neurology at Michigan Medicine-University of Michigan, joins the podcast to discuss the recently published American Academy of Sleep Medicine clinical practice guideline on combination treatment for chronic insomnia disorder in adults. Arnedt explains the rationale behind formal recommendations for concurrent use of cognitive behavioral therapy for insomnia (CBT-I) and pharmacotherapy, particularly as combination treatment becomes increasingly common in clinical practice. The conversation reviews the evidence supporting CBT-I as the preferred foundational treatment approach, where combination therapy may offer advantages over pharmacotherapy alone, and how clinicians should think about factors such as symptom burden, treatment goals, access to CBT-I, and patient preference when selecting treatment strategies. Arnedt also outlines ongoing research gaps involving sequential treatment approaches, medication classes, long-term outcomes, and personalized insomnia care. Looking for more Sleep Disorders discussion? Check out the NeurologyLive® Sleep Disorders clinical focus page.Episode Breakdown: 1:15 – Why formal insomnia combination treatment guidance was needed 2:45 – Defining concurrent CBT-I and pharmacotherapy approaches 4:35 – Evidence supporting CBT-I as foundational insomnia treatment   7:15 – Situations where combination therapy may improve patient outcomes 7:50 – Neurology News Network  10:20 – Patient-specific factors influencing insomnia treatment selection 12:30 – Barriers involving CBT-I access, cost, and real-world implementation 16:55 – Research gaps surrounding sequencing, long-term outcomes, and personalization The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: Topline Phase 2 CELIA Results Show Diranersen Misses Primary End Point in Early Alzheimer Disease FDA Grants Priority Review to Bayer's Asundexian for Secondary Stroke Prevention Dyne Submits BLA for Z-Rostudirsen in Exon 51 Skipping Duchenne Muscular Dystrophy Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

In this episode of Talking Sleep, host Dr. Seema Khosla welcomes Dr. Daniel Buysse and Dr. Todd Arnedt, both members of the AASM clinical practice guideline committee, to discuss the newly released guidelines on combination treatment for chronic insomnia disorder in adults. Unlike previous guidelines, this new guidance specifically addresses what happens in real-world clinical practice: patients often request both cognitive behavioral therapy for insomnia (CBT-I) and pharmacotherapy, or arrive seeking medications while clinicians advocate for behavioral interventions. The guidelines provide evidence-based recommendations for navigating these combination treatment scenarios, incorporating patient preferences in ways previous guidelines did not. The conversation explores the guideline development process, including how committee members were selected and how diverse professional backgrounds enriched the discussion. Dr. Buysse and Dr. Arnedt explain why patient preference wasn't adequately reflected in original practice guidelines and how this updated version addresses that gap. The first recommendation receives detailed examination: In adults with chronic insomnia, the AASM suggests combination treatment with CBT-I plus medication over medication alone (conditional recommendation, low certainty of evidence). The experts clarify which medications were examined, including whether dual orexin receptor antagonists (DORAs) were included, and explain why evidence certainty is low despite numerous studies. Pharmaceutical sponsorship creates methodological differences—PSG outcomes, fixed time in bed requirements—that complicate interpretation. The high placebo response in insomnia trials adds another layer of complexity. Critical implementation questions arise: What does "combination therapy" actually mean? Should both treatments start simultaneously, or should one precede the other? Can patients start medications while awaiting CBT-I appointments given typical access delays? The second recommendation appears paradoxical: The AASM suggests against combination treatment over CBT-I alone, yet recommends combination over medication alone. Dr. Buysse and Dr. Arnedt explain this nuanced position—CBT-I alone remains superior, but for patients who prioritize rapid total sleep time improvement over daytime symptom reduction, combination therapy may be reasonable. The conversation addresses whether treatment order matters and whether clinical (not just insurance-driven) logic suggests a medication hierarchy—zolpidem before eszopiclone, the role of trazodone, when to consider ramelteon. A crucial question emerges: What about patients who refuse or cannot access CBT-I? How do these guidelines apply when the preferred behavioral treatment is unavailable or unwanted? Throughout, the experts emphasize that guidelines inform but don't dictate clinical decisions. Patient preferences, values, and individual circumstances must shape treatment plans. The guidelines provide evidence-based frameworks while acknowledging the complexity of real-world insomnia management. Whether you're treating chronic insomnia, navigating patient requests for medications, addressing CBT-I access barriers, or seeking evidence-based approaches to combination therapy, this episode provides essential guidance. Join us for this important conversation about balancing behavioral and pharmacological approaches to chronic insomnia in clinical practice.

In this episode of Talking Sleep, host Dr. Seema Khosla welcomes Dr. Reena Mehra, professor in the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Washington in Seattle, and Dr. Dennis Aukley, professor in the Division of Pulmonary, Critical Care, and Sleep Medicine at MetroHealth Medical Center, Case Western Reserve University in Cleveland, to discuss the newly released AASM clinical practice guidelines for evaluating and managing obstructive sleep apnea in hospitalized adults. The guidelines address a significant gap in inpatient care: how to systematically screen for sleep apnea in hospitalized patients, prioritize high-risk groups, determine when and where to perform testing, and ensure appropriate outpatient follow-up. Dr. Mehra and Dr. Aukley explain the impetus behind developing these guidelines and the PICO question process used to examine existing evidence, acknowledging the challenges of working with limited data in this emerging field. The conversation systematically walks through the four key recommendations: in-hospital screening for OSA as part of an evaluation and management pathway, use of inpatient PAP treatment for newly diagnosed or untreated moderate-to-severe OSA, availability of sleep medicine consultation, and implementation of discharge management plans to ensure timely diagnosis and effective outpatient management. Practical implementation receives extensive attention. How should patients be screened—using STOP-Bang or facility-specific methods? Should screening be built into the EMR? Which patient populations and hospital units should be prioritized? Who performs the screening—sleep navigators, nursing staff, or hospitalists? Can sleep consultations be conducted via telemedicine at the bedside? The experts emphasize the critical need for a program champion and comprehensive education initiatives. Dr. Aukley shares invaluable lessons from his experience creating an inpatient sleep program, discussing what he wishes he'd known before starting and practical insights gained through implementation. A particularly frustrating issue receives attention: patients who bring their own PAP devices to the hospital but never have them set up or used during their stay. The guidelines address this common scenario and provide frameworks for ensuring treated patients continue therapy during hospitalization. Legal liability considerations are explored: What responsibilities exist for untreated patients diagnosed with OSA during hospitalization? What about high-risk patients who haven't been formally diagnosed? The experts discuss strategies for ensuring outpatient follow-up, recognizing that effective discharge planning is essential for translating inpatient identification into long-term management. Whether you're considering establishing an inpatient sleep program, frustrated by gaps in hospital-based sleep apnea care, or seeking evidence-based approaches to identifying and managing OSA in hospitalized patients, this episode provides essential guidance and practical implementation strategies. Join us for this important discussion about bringing systematic sleep apnea evaluation and management into the inpatient setting.

Dr. Anita Shelgikar of the American Association of Sleep Medicine has the science to back up why we should stop "Spring Forward"

Restless legs syndrome used to feel simple. If the legs were jumping, we reached for a dopamine agonist, the safer alternative to older meds. Over time, we learned that the very medication calming symptoms could make the condition worse. But just as guidelines changed in favor of gabapentin and related medications, new research raised concerns about the medications link to cognitive decline and dementia. So where does that leave patients? In this episode, we will:Define restless legs syndrome and review why dopamine agonists became the standard treatment in the first placeExplain augmentation and rebound in plain language, and why it led to guideline reconsiderationWalk through the AASM's updated recommendations and why gabapentinoids are now considered first-line therapyExamine the recent study linking gabapentin exposure to increased dementia and mild cognitive impairment riskDiscuss what observational research can and cannot tell us about causationCompare the real-world risks of dopamine agonists versus the emerging safety signals around gabapentinExplore how these recommendations may be interpreted differently by sleep specialists versus primary care providersHighlight the “rock and hard place” many patients feel caught in when every option carries caveatsReview practical strategies: iron optimization, careful dosing, monitoring for augmentation, and individualized careOffer a balanced framework for making thoughtful, evidence-based decisions without panic or oversimplificationProduced by: Maeve WinterMore Twitter: @drchriswinter IG: @drchriwinter Threads: @drchriswinter Bluesky: @drchriswinter The Sleep Solution and The Rested Child Thanks for listening and sleep well!

In this season 8 premiere of Talking Sleep, host Dr. Seema Khosla welcomes three members of the AASM guideline committee—Dr. Rami Khayat, Professor and Division Chief of Pulmonary, Allergy & Critical Care Medicine and Director of Penn State Health Sleep Services; Dr. Shirine Allam, Professor of Medicine at Emory University and Program Director for the Pulmonary and Critical Care Fellowship at the Atlanta VA Medical Center; and Dr. Christine Won, Medical Director of Yale Centers for Sleep Medicine and Professor of Medicine at Yale University—to discuss the newly released AASM clinical practice guidelines for central sleep apnea treatment. The conversation begins with the rigorous process behind guideline development, clarifying the distinction between evidence-based recommendations and expert opinion. The panel systematically walks through each recommendation, addressing CPAP use across various CSA etiologies including primary CSA, heart failure-related CSA, medication-induced CSA, treatment-emergent CSA, and CSA due to medical conditions. A surprising recommendation against BPAP without backup rate generates discussion about why backup rates matter and why heart failure patients are excluded from certain BPAP recommendations. The experts tackle the controversial topic of adaptive servo-ventilation (ASV), explaining why it's now conditionally recommended even for heart failure patients despite SERVE-HF trial concerns. They clarify that newer ASV algorithms differ from devices used in that study and emphasize the importance of patient-provider shared decision-making and treatment at experienced centers. Practical implementation guidance covers oxygen therapy for heart failure and high-altitude CSA, including insurance coverage challenges. The panel discusses acetazolamide use across multiple CSA etiologies, providing concrete advice on prescribing and follow-up protocols. Transvenous phrenic nerve stimulation receives attention as an option for select patients, with candid discussion about its invasive nature, accessibility limitations, and high costs. The episode addresses the shift toward viewing CSA treatment as chronic disease management, including billing code G211 implications. The experts emphasize that guidelines guide but don't constrain clinical judgment, stressing the importance of monitoring beyond AHI—including patient symptoms and quality of life improvements. Whether you're treating complex central sleep apnea, navigating insurance coverage, or seeking clarity on when ASV is appropriate, this review provides essential guidance for implementing evidence-based CSA treatment. Join us for this season premiere that translates complex guidelines into practical clinical applications.

This special episode is brought to you by Zoll RespicardiaIn this episode of SleepTech Talk, we explore the newest breakthroughs in treating Central Sleep Apnea (CSA).Our guest, Timothy Morgenthaler, MD, Professor and Vice Chair, Quality and Affordability at the Mayo Clinic, and past President of the American Academy of Sleep Medicine (AASM), helps explain the updated AASM treatment guidelines and how Transvenous Phrenic Nerve Stimulation (TPNS) is now recognized as an effective therapy for CSA.We also dive deep into the Remede implant, an FDA-approved TPNS device that stimulates the phrenic nerve to help patients breathe normally during sleep. Dr. Morgenthaler breaks down how it works, which patients may benefit most, and what the AASM's new recommendations mean for clinicians and patients going forward.⭐ Main topics we cover:What's new in the AASM guidelines for Central Sleep Apnea (2025 update)Why TPNS is now an accepted therapy for CSAHow the Remede implant works and who it helpsDifferences between obstructive, central, and complex sleep apneaReal-world impact of the updated guidelines on patient careWhere TPNS fits among PAP therapy, ASV, oxygen, medications, and other treatmentsWhether you're a sleep clinician, technologist, or someone affected by sleep apnea, this episode provides a clear, practical breakdown of the latest evidence-based options for CSA.Learn more about Remede athttps://remede.zoll.com/ ABOUT SLEEPTECH TALKSleepTech Talk brings together leaders in sleep medicine, technology, and innovation to explore the tools and trends shaping the future of sleep health.Catch the show on most podcast platforms or on YouTubewww.youtube.com/@sleeptechtalk Don't forget to Like, Share, and Comment! Subscribe to SleepTech Talk for more insights into sleep apnea, CPAP therapy, and innovations shaping the future of sleep care.Whether you're a sleep professional or a healthcare innovator, this episode explores the intersection of technology, patient care, and sleep medicine.Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2025 SleepTech Talk ProductionsEpisode 112The views and opinions expressed by guests on SleepTech Talk are their own and do not necessarily reflect those of the podcast hosts or SleepTech Talk as a whole. This podcast is intended for educational and informational purposes only and should not be considered medical advice. Listeners are encouraged to consult with a qualified healthcare professional for any medical concerns or questions.Sleep apnea, obstructive sleep apnea, oral sleep appliance, inspire, surgery, sleep surgery, CPAP, AI, Artificial Intelligence

De passage en France, Volodymyr Zelensky a signé une “lettre d'intention” pour l'achat de cent avions de chasse Rafale, des drones, des systèmes de défense aérienne SAMP-T ou des bombes guidées AASM, le tout pour un montant évalué entre 10 et 15 milliards €. Mais avant que ces intentions ne se transforment en commande ferme, il y a de nombreux obstacles à surmonter, à commencer par le financement de ces achats.

Dr. Karin Johnson of AASM discusses why it's healthier for us to stay at Standard Time, as opposed to Daylight-Saving time

In this episode of Talking Sleep, host Dr. Seema Khosla welcomes Dr. Doug Kirsch, Medical Director of Atrium Health Sleep Medicine and Clinical Professor in the Department of Neurology at Wake Forest School of Medicine, and Dr. Fariha Abbasi-Feinberg, president-elect of the AASM and private practice physician with Millennium Physician Group in Fort Myers, Florida, to introduce PLATO—a groundbreaking longitudinal assessment tool for obstructive sleep apnea. The Epworth Sleepiness Scale has been a cornerstone of sleep medicine practice for decades, yet clinicians universally acknowledge its limitations in capturing the full patient experience. Similarly, PAP adherence—while important and part of Medicare's MIPS program—tells only part of the story about treatment success. During his AASM presidency, Dr. Kirsch recognized the need for a more comprehensive metric and convened an expert advisory panel to develop a better solution. The conversation traces PLATO's development journey, which Dr. Rosen described as "Doug's baby with a prolonged gestation." Starting with 44 potential questions and utilizing the ICON methodology, the panel carefully refined the tool to capture domains beyond simple sleepiness—including quality of life, functional impairment, and symptom burden that the Epworth overlooks. Dr. Kirsch and Dr. Abbasi-Feinberg explain the validation process, how the tool discriminates between OSA severity levels, and why certain seemingly similar questions about sleepiness were all retained. The episode addresses practical implementation questions: How is PLATO scored? Why do the first two sections use 5-point scales while the final section uses 10 points? Is it free to use, and how does one access it? Will it integrate into electronic health record systems like Epic? Most importantly, how should clinicians use this tool—will it replace the Epworth for Medicare requirements, or does it serve a different purpose? The discussion also explores how PLATO relates to the recent AHRQ report on OSA treatment outcomes and why the tool focuses on patient-reported symptoms rather than solely cardiovascular endpoints. Dr. Kirsch shares his vision for PLATO's future, including hopes for foundation grants to further study the tool and demonstrate that treating OSA and its associated sleepiness meaningfully improves patient outcomes. Whether you're frustrated with current assessment limitations, interested in value-based care metrics, or seeking better ways to document treatment efficacy beyond adherence data, this episode provides essential insights into a tool that may reshape how we measure success in sleep medicine. Join us for this important discussion about moving beyond PAP adherence and Epworth scores to truly capture what matters to our patients.

Is my CPAP helping me?Have you wondered if your OSA therapy really working for you? Is that CPAP really helping your OSA? What about if you are using an oral appliance? What about an implant?What about nasal strips?!In this episode, the STT Crew talk to Doug Kirsch, MD about the patient reported outcome tool recently released by the American Academy of Sleep Medicine (AASM).Dr Kirsch is with Atrium Health, based out of Charlotte, North Carolina is also a past president of the AASM. He was instrumental in getting a patient reported tool started and developed while he was at the AASM.He talks about the need for patient reported outcomes of OSA therapies. He talks about how we often use the adherence data from PAP machines, but what about other therapies? He also talks of those patients that may not use the “required” 4 hours of PAP therapies, but they feel better; so how do we measure those outcomes?Listen in as Dr Kirsch talks about PLATO, the Patient-reported Longitudinal Assessment Tool by the American Academy of Sleep Medicine.Catch the show on most podcast platforms or on YouTubehttps://youtu.be/Qo7CwSYVDOwA huge thanks to our sponsors:Medbridge Healthcare  : For Job Opportunities with MedBridge Healthcare visit: https://medbridgehealthcare.com/careers/Fisher & Paykel Healthcare  Discover how F&P full-face masks have led millions of people to a great night's sleep at https://www.fphcare.com/curiosityhttps://www.fphcare.com/us/homecare/sleep-apnea/React Health  https://www.reacthealth.com/More resources for clinicians can be found at Sleep Review Magazine  https://sleepreviewmag.com/Don't forget to Like, Share, Comment, and Subscribe!Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2025 SleepTech Talk ProductionsEpisode 108The views and opinions expressed by guests on SleepTech Talk are their own and do not necessarily reflect those of the podcast hosts or SleepTech Talk as a whole. This podcast is intended for educational and informational purposes only and should not be considered medical advice. Listeners are encouraged to consult with a qualified healthcare professional for any medical concerns or questions.Sleep apnea, obstructive sleep apnea, oral sleep appliance, inspire, surgery, sleep surgery, CPAP, AI, Artificial Intelligence

In this special episode of Talking Sleep, host Dr. Seema Khosla offers an exclusive preview of the upcoming SleepMedicine Disruptors course, taking place November 14-15 in Austin, Texas. She speaks with Steve Van Hout, executive director of the AASM, and Dr. David White, professor of medicine part time at Harvard Medical School, about the groundbreaking innovations reshaping sleep medicine. Steve Van Hout explains what makes the Disruptors conference unique compared to other AASM meetings like Trends and the annual SLEEP conference. Designed to bring together clinicians, researchers, technology innovators,and venture capitalists, Disruptors aims to foster cross-industry collaboration and encourage investment in sleep medicine innovations. The conference features innovation award presentations similar to Shark Tank pitches with the audience voting on their favorites, keynote speakers, and discussions about emerging technologies that promise to transform how we diagnose and treat sleep disorders. Dr. White provides an in-depth preview of his presentation on pharmacotherapy for obstructive sleep apnea, sharing exciting developments in multiple drug candidates. He discusses Apnimed's AD-109, a combination of atomoxetine and R-oxybutynin, which has completed two phase three studies showing approximately 50% reduction in AHI across six-month and one-year trials involving over 650 patients each. With FDA submission planned for early 2026, this medication could reach the market by late 2026. The conversation explores other promising agents including Incannex's combination of dronabinol and acetazolamide, carbonic anhydrase inhibitors like sulthiame (recently licensed by Apnimed), and innovative potassium channelantagonists that could be delivered via nasal spray for localized upper airway effects with minimal systemic absorption. Dr. White discusses the potential for poly therapy approaches, combining medications with devices like mandibular advancement devices or positional therapy, drawing parallels to how hypertension and diabetes are managed with multiple treatments. The episode tackles important questions about the future of sleep medicine: Will pharmacotherapy replace PAP therapy, or will hybrid approaches become standard? What AHI reduction is clinically meaningful for cardiovascularprotection and symptom improvement? How will pricing and insurance coverage affect accessibility? They emphasize that while these medications may not replace CPAP entirely, they offer promising options for patients who struggle with existing therapies. Whether you're a sleep medicine practitioner interested in emerging treatments, an entrepreneur exploring innovation opportunities, or simply curious about the future of sleep disorder management, this episode provides essential insights into the rapidly evolving landscape of sleep medicine. Join us for this forward-looking conversation about innovation, investment, and the technologies poised to disrupt traditional sleep medicine practice.

Why do some toddlers nap like champs while others refuse entirely? In Part 1 of our Napping Spectacular, Craig and Arielle unpack what the science says about total sleep needs, how nap patterns change across infancy and early childhood, and the very real “art” of troubleshooting naps at home. We cover when to drop naps, how brain development (especially the hippocampus) affects nap transitions, what to do about short naps, and how to keep daytime sleep from stealing restorative overnight sleep. We also talk through safe approaches to contact naps and why it's normal for newborns to have unpredictable naps and periods of crying. Key takeaways Think in 24 hours: aim to balance daytime sleep with restorative overnight sleep. AASM consensus ranges: infants 4–12 mo (12–16 h), toddlers 1–2 y (11–14 h), preschoolers 3–5 y (10–13 h), school-age 6–12 y (9–12 h), teens 13–18 y (8–10 h). Nap transitions are tied to brain maturity; as memory systems develop, many preschoolers naturally nap less. Typical goals for many infants: at least two naps of ~1 hour each and ~10 hours overnight (individual needs vary). Independent sleep skills are the linchpin for extending naps beyond a single 30–45 minute sleep cycle. Watch sleepy cues, but remember boredom can masquerade as tiredness in older infants. Contact napping can be soothing, but it's risky if the caregiver is truly exhausted—prioritize safe sleep. Newborn naps are erratic; you can practice gentle routines, but you can't “schedule” a newborn. Consistency across naps and nights helps babies learn faster than a mix-and-match approach. Links CIO episode of the Sleep Edit Dr. Canapari's article on Le Pause Sleep training Period of purple crying Dr. Canapari's article on napping Dr. Canapari's article on sleep needs in children Arielle's website Chapters 00:00 Intro and disclaimer 01:10 Why naps feel harder than nights; personal stories 03:00 What parents often misunderstand about naps 04:00 How much sleep kids need (AASM consensus) 06:00 Why naps matter for mood and learning 06:40 Brain development and nap transitions (hippocampus) 07:00 Average nap duration by age; variability is normal 09:10 How many naps per day; typical progression through early childhood 12:00 Galland review; why transitions are tricky in real life 14:00 The “art” of troubleshooting naps 15:00 Naps vs. nights: balance the 24-hour total 18:00 Targets for infants; prioritizing overnight sleep 22:00 High vs. low sleep-need babies 23:00 Nap routines vs. bedtime routines; wind-down for toddlers 25:00 How to get longer naps: schedule fit and independent sleep 27:00 Evidence-based infant sleep tips (INSIGHT and SAAF principles) 29:00 Reading sleep cues without getting trapped by rigid schedules 30:30 Overtiredness vs. boredom; case example 34:00 Can you sleep-train for naps but not nights? Why consistency wins 36:00 Typical nap times by age; capping late naps 39:00 Newborn nap reality check 40:00 Contact napping and safety 42:00 Period of PURPLE Crying and parental stress 45:30 Wrap-up and preview of Part 2 References Paruthi S, Brooks LJ, D'Ambrosio C, et al. Consensus statement of the American Academy of Sleep Medicine on the recommended amount of sleep for healthy children: methodology and discussion. Journal of Clinical Sleep Medicine. 2016;12(11):1549-1561. Spencer RMC, Riggins T. Contributions of memory and brain development to the bioregulation of naps and nap transitions in early childhood. Proceedings of the National Academy of Sciences. 2022;119(11):e2114326119. Staton S, et al. Many naps, one nap, none: A systematic review and meta-analysis of napping patterns in children 0–12 years. Sleep Medicine Reviews. 2020;50:101247. Galland BC, Taylor BJ, Elder DE, Herbison P. Normal sleep patterns in infants and children: A systematic review of observational studies. Sleep Medicine Reviews. 2012;16(3):213-222. Horváth K. Spotlight on daytime napping during early childhood. Frontiers in Psychology. 2018;9:1238. Wolke D, Bilgin A, Samara M. Fussing and crying durations and prevalence of colic in infants: Systematic review and meta-analysis. The Journal of Pediatrics. 2017;185:55-61.e4. Lavner JA, Hohman EE, Beach SRH, Stansfield BK, Savage JS. Effects of a responsive parenting intervention among Black families on infant sleep: Secondary analysis of the Sleep SAAF randomized clinical trial. JAMA Network Open. 2023;6(3):e236276. Paul IM, Savage JS, Anzman-Frasca S, Marini ME, Mindell JA, Birch LL. INSIGHT Responsive Parenting Intervention and infant sleep. Pediatrics. 2016;138(1):e20160762. Contact Listener questions: sleepeditpod@gmail.com

 In this episode of Talking Sleep, host Dr. Seema Khosla sits down with Dr. Anita Shelgikar, current president of the American Academy of Sleep Medicine, neurologist, and sleep fellowship program director at the University of Michigan, for a transparent look at how the AASM makes critical decisions that shape the field of sleep medicine.  Ever wondered how clinical practice guidelines are developed and why updates take so long? Dr. Shelgikar pulls back the curtain on the comprehensive process behind guideline creation, from topic selection to evidence review to final publication. She explains how the AASM prioritizes which guidelines need updating and how members can influence these decisions.  The conversation addresses pressing concerns facing sleep medicine practitioners: the ongoing review of home sleep apnea testing codes, declining reimbursement rates, and the financial viability of sleep medicine practices. Dr. Shelgikar discusses the AASM's advocacy efforts, recent legislative wins and setbacks, and strategies for improving the value proposition of polysomnography in an evolving healthcare landscape.   Looking toward the future, the discussion explores emerging trends including the potential for inpatient sleep medicine services, the shift toward chronic disease management models, and new technologies like acoustic stimulation. Dr. Shelgikar shares insights on how the field might evolve beyond its traditional testing-focused approach and adapt to changing reimbursement structures.  The episode also demystifies AASM governance: How are committees formed and sunset? Why can't every volunteer serve? What happens during board meetings? Is board membership reserved for academics? Dr. Shelgikar provides practical guidance on how members can engage more meaningfully with the organization and influence its direction.   Whether you're a longtime AASM member curious about organizational decision-making or a newer member seeking to understand how to get involved, this episode offers valuable transparency into the processes that shape sleep medicine policy and practice.  Join us for this informative conversation that bridges organizational leadership with frontline clinical concerns in sleep medicine. 

In this episode of Talking Sleep, host Dr. Seema Khosla welcomes Dr. Imran Iftikhar and Dr. Rami Khayat to discuss groundbreaking research on adaptive servo-ventilation (ASV) and the newly released AASM clinical practice guidelines for central sleep apnea treatment. Dr. Iftikhar presents his innovative approach to analyzing ASV data through meta-analysis combined with trial sequential analysis, offering fresh insights into the statistical reliability of existing research beyond traditional systematic reviews. His work addresses lingering questions about ASV efficacy and safety that have persisted since the controversial SERVE-HF trial results challenged previous assumptions about this therapy. Meanwhile, Dr. Khayat, who served as vice-chair of the AASM task force, walks through the comprehensive evidence-based recommendations covering the full spectrum of central sleep apnea treatments. The guidelines address critical clinical decisions: When should CPAP be used over no treatment? Who requires BPAP with backup rates? Why does the task force recommend against BPAP without backup rates for central sleep apnea? What role do oxygen, acetazolamide, and transphrenic nerve stimulation play in treatment algorithms? The conversation delves into practical considerations including differences between ASV device algorithms from various manufacturers, the clinical impact of current device availability issues, and findings from Dr. Parthasarathy's bench study. The experts tackle the complex question of ASV use in patients with reduced ejection fraction and clarify important distinctions between primary central sleep apnea and treatment-emergent central sleep apnea (TECSA). This episode addresses the evolving landscape of central sleep apnea management, helping clinicians navigate evidence-based treatment decisions in an era of changing technology and updated safety considerations. Whether you're treating patients with heart failure, complex sleep-disordered breathing, or emerging central events during PAP therapy, this episode provides essential guidance for optimizing care. Join us for this comprehensive update that translates complex research findings into practical clinical applications.

In this episode of Talking Sleep, host Dr. Seema Khosla welcomes Dr. Luca Baldelli, a neurologist from the University of Bologna and Treasurer-Elect of the International REM Sleep Behavior Disorder Study Group, to discuss breakthrough research on predicting which RBD patients will develop neurodegenerative diseases. Building on the AASM's updated RBD guidelines, Dr. Baldelli presents compelling evidence for using simple autonomic reflex testing to identify patients at highest risk for phenoconversion to conditions like Parkinson's disease and dementia with Lewy bodies. His research demonstrates that objective autonomic testing, particularly orthostatic assessments, can reveal early neurogenic orthostatic hypotension that precedes overt neurodegeneration by years. The conversation explores practical clinical applications: How can sleep medicine practitioners implement these screening protocols? What constitutes abnormal autonomic function in RBD patients? How do we interpret changes over time, and when should patients be referred for neurological evaluation? Dr. Baldelli shares his longitudinal monitoring framework that could transform how we counsel RBD patients about their future risk. This episode addresses critical questions about biomarker development in prodromal neurodegeneration, the timeline of autonomic changes, and evidence-based approaches to patient discussions about prognosis. Dr. Baldelli also discusses current research initiatives and potential therapeutic interventions for high-risk patients. Whether you're a sleep medicine physician, neurologist, or researcher interested in neurodegenerative diseases, this episode provides essential insights into improving early detection and patient care in RBD. Join us for this informative discussion that bridges sleep medicine and neurology to enhance clinical decision-making and patient outcomes.

Los adolescentes que prefieren dormir y despertarse más tarde son más impulsivos que los adolescentes “madrugadores”, informan los investigadores en la próxima reunión anual de la Academia Americana de Medicina del Sueño (American Academy of Sleep Medicine, AASM).

Dr. Jocelyn Cheng of AASM say NO. We should stay on Standard time because there are too any health risks associated with losing an hour

In this episode, host Dr. Seema Khosla explores KPAP, a new PAP therapy innovation with Dr. David White, former AASM president, and Dr. William Noah, inventor of the V-com device. Learn about this new technology that promises to make positive airway pressure more comfortable while still remaining effective for sleep apnea patients. Discover the science behind KPAP, its potential advantages over traditional CPAP, and how it addresses issues like treatment-emergent central apneas and CO2 rebreathing. The discussion covers the device's development, clinical trial results, and implications for sleep apnea treatment, offering insights for clinicians and patients alike.

Meet Eric Olson, MD. Dr Olson is a pulmonologist, critical care specialist, and sleep specialist at the Mayo Clinic. He is also the newly elected President of the American Academy of Sleep Medicine. Listen in as the STT Crew talk to Dr Olson about his role in the AASM, his work at the Mayo Clinic, and his thoughts on sleep medicine in 2025. Also, learn what's "better together" during this discussion. There's a lot of exciting discussion in this episode; a lot to unpack, so listen up! https://www.mayoclinic.org/biographies/olson-eric-j-m-d/bio-20053858 https://foundation.aasm.org/about/board-of-directors/eric-j-olson/ A huge thanks to our sponsor: Medbridge Healthcare: For Job Opportunities with MedBridge Healthcare click here: https://medbridgehealthcare.com/careers/ Don't forget to Like, Share, Comment, and Subscribe! Learn more about the show at https://www.sleeptechtalk.com/thetechroom Credits: Audio/ Video: Diego R Mann; Music: Pierce G Mann Hosts: J. Emerson Kerr, Robert Miller, Gerald George Mannikarote Copyright: ⓒ 2025 SleepTech Talk Productions Episode 92 Sleep apnea, obstructive sleep apnea, oral sleep appliance, inspire, surgery, sleep surgery, CPAP

Sleep trackers - what are they good for? While they may give you an entertaining look at your sleep health, they can complicate treatment of sleep disorders. Our guest today, Dr. Diana Dolan, returns to P4P to provide a balanced view on consumer wearables and their impact on sleep assessment and treatment. Technology has evolved in the past few years, and so have our suggestions for how to work with patients who love their sleep trackers. How can we capitalize on our patients' enthusiasm for better sleep? Tune in to find out.Diana Dolan, Ph.D., CBSM, DBSM, is a clinical psychologist serving as an Associate Director of Training & Education with the Center for Deployment Psychology (CDP) at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. She currently oversees programs that provide evidence-based training for military-connected patients on a variety of topics. She is certified in Behavioral Sleep Medicine by the American Board of Sleep Medicine. She is also a diplomate in Behavioral Sleep Medicine from the Board of Behavioral Sleep Medicine.Resources mentioned in this episode: de Zambotti, M., Goldstein, C., Cook, J., Menghini, L., Altini, M., Cheng, P., & Robillard, R. (2024). State of the science and recommendations for using wearable technology in sleep and circadian research. SLEEP 47: 1-31. https://doi.org/10.1093/sleep/zsad325Khosla S, Deak MC, Gault D, Goldstein CA, Hwang D, Kwon Y, O'Hearn D, Schutte-Rodin S, Yurcheshen M, Rosen IM, Kirsch DB, Chervin RD, Carden KA, Ramar K, Aurora RN, Kristo DA, Malhotra RK, Martin JL, Olson EJ, Rosen CL, Rowley JA; American Academy of Sleep Medicine Board of Directors. Consumer sleep technology: an American Academy of Sleep Medicine position statement. J Clin Sleep Med. 2018;14(5):877–880.CBT-I Coach app. Includes a sleep diary that may appeal to patients who prefer to use apps and other technology. https://mobile.va.gov/app/cbt-i-coach Calls-to-action: For example: Become familiar with the American Academy of Sleep Medicine's position on consumer wearables: “It is the position of the AASM that CST must be FDA cleared and rigorously tested against current gold standards if it is intended to render a diagnosis and/or treatment. Given the unknown potential of CST to measure sleep or assess for sleep disorders, these tools are not substitutes for medical evaluation. However, CSTs may be utilized to enhance the patient-clinician interaction when presented in the context of an appropriate clinical evaluation.”Subscribe to the Practical for Your Practice PodcastSubscribe to The Center for Deployment Psychology Monthly Email Send us your questions and feedback! Voicemail: speakpipe.com/cdpp4pEmail: cdp-podcast-ggg@usuhs.edu

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, Andy Berkowski, MD, PhD, founder of Relax Health, sat down to discuss the American Academy of Sleep Medicine's (AASM) recently published guideline update for the treatment of restless legs syndrome (RLS). Berkowski, who serves as a vice chair of the AASM's Practice Guidelines Task Force, provided clinical insight on the reasons behind the guidelines, pointing to the vast research advances and literature updates since its last iteration in 2012. Additionally, he touched on the greatest changes to the guidelines, noting things like the shift away from dopaminergic agents, the importance of iron in RLS pathophysiology, and the use of alpha-2-delta ligands and intravenous iron as first-line treatments. Berkowski also shared thoughts on how the guidelines impact care for patients of all ages, sexes, and RLS subtypes, as well as some of the more troubling parts of the guidelines to write and areas that were left unanswered. Furthermore, he gave his thoughts on how these guidelines will transform care going forward, including accelerating conversations on preventing RLS in many cases in the near future. Looking for more epilepsy discussion? Check out the NeurologyLive® Sleep disorders clinical focus page. Episode Breakdown: 1:00 – Reasons behind new guidelines, progress in clinical research 2:50 – Overview of the greatest changes to the guidelines and what treating physicians should key in on 11:25 – Neurology News Minute 13:40 – How the guidelines address management based on age, sex, and RLS subtype 16:30 – Challenges when drafting the guidelines and the unanswered questions that remain 20:10 – A promising future for treating, managing, and preventing RLS The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: Neurogene Reports Serious Adverse Event in Phase 1/2 Rett Study of Gene Therapy NGN-401 Huntington Agent SAGE-718 to be Discontinued Following Disappointing Phase 2 DIMENSION Trial Results Alzheimer Agent Simufilam Fails to Meet Primary End Point in Phase 3 Study Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

In this episode of Talking Sleep, Drs. John Winkelman and Andy Berkowski discuss the updated AASM clinical practice guideline for the treatment of restless legs syndrome and periodic limb movement disorder.

Dr. Karin Johnson of AASM explains that turning the clocks back is healthier than turning the clocks forward an hour, but each has health risks

Join me for a summary looking into the increasingly popular topic of paediatric obstructive sleep apnoea, a review of orthodontic treatments available, and how effective they are in this growing field of both medicine and dentistry. This episode is a summary of Alberto Capriglio's lecture from the AAO and Carlos Flores Mir's lecture at the IOF earlier this year.     OSA - Defined upper airway dysfunction causing complete or partial airway obstruction during sleep   Sleep = Slow wave sleep – constructive phase of sleep (recuperation of the mind) ·      Growth hormones secreted ·      Glial cells within brain restored ·      Cortical synapses increase in number – Moberget 2019   Outcomes to paediatric patients of SDB: (AASM) ·      delays in development,  Poor academic performance, Aggressive behaviour, attention- deficit/hyperactivity disorder, , emotional problems in adolescence   First line medical treatment – adenotonsillectomy  ·      40% residual  OSA       Effect palatal expansion 1.        Roof the mouth = base of the nose - Increase in nasal airway volume - Reduction in OSA, if obstruction in naso-pharynx, 2.        Short term reduction in OSA (not cure AASM) a.        20% improvement in AHI, 85% of cases Villa 2015 b.        15% got worse by 20% c.        57.5% residual AHI greater than 1 - not resolution 3.        Caprioglio 2019 long term AHI return to initial scores, from 7 to 5 long term 4.        Change in metabolism when combined with Vit D3 a.        Vit D3 with RME increases reduction in AHI, sustained long term, Caprioglio 2019 AHI 61.9% Vs 35.5% long term     Expansion other outcomes -  school performance  Bariani 2024 ·      AJODO – RME improves academic performance – o   BEHAVOUR 1 of 8 parameters improved only for academic performance  - change small 0.68 o   COGNITIVE 1 in 8 improve       Mandibular advancement Move mandible forwards and open space behind the tongue – oropharynx ·      Anatomical – increase size of oropharangeal airway ·      YAnyAn 2019 mandibular advancement for pOSA systematic review:  1.75 AHI reduction (CI) −2.07, −1.44) – modest change ·      However long term use required of the paediatric patient     Orofacial features in children with obstructive sleep apnea.  Fagundes Flores-Mir 2022 o   No craniofacial features specific to pOSA – ANB, o   However medical diagnosis through polysomnography may under-estimate incidence, o   Broader diagnosis such as snoring, may over-estimate OSA   AADSM 2024 – consensus statement ·      Expansion o   Prevention: No consensus o   Management: No consensus o   Cure: Insufficient ·      Mandibular advancement o   Prevention, management, cure – unclear   More about OSA? To hear more about OSA, please check out the last interview on orthodontics in interview with Sanjivan Kandasamy, where we had a deep dive into OSA and where we are in our understanding today from the research Interview with Sanjivan Kandasamy on OSA                          

The AASM is introducing a new service-based accreditation model and updated Standards for Accreditation, which will take effect in January 2025. Based on feedback from members and accredited programs, this accreditation model provides greater flexibility to accommodate all practice types, making it easier to manage, add, and remove accredited services. Changes to the Standards for Accreditation were also made to remove barriers and promote administrative and operational efficiencies in sleep practice management. In this episode, AASM Accreditation Committee Chair Dr. Fady Jamous and AASM Director of Accreditation Ray Anthonijsz help explain some upcoming changes to AASM accreditation programs.

AI is popping up everywhere — when we open a PDF, use an AI scribe, or look something up with Chat GPT. We all interface with AI daily and may not even realize it. This can become very complex and somewhat mysterious. How can we use AI in a sleep medicine practice? Is it trustworthy? Will we all be replaced by AI someday? The AASM has an AI committee tasked with these questions. In this episode, we talk with committee members Dr. Margarita Oks and Matt Anastasi about a SWOT analysis on the use of AI-enabled technology in sleep medicine.

Get a behind-the-scenes look at the meticulous planning for RubyConf, where  Kinsey Durham Grace reveals exciting new initiatives aimed at making the conference more inclusive and accessible for developers of all skill levels. Learn about the importance of the early Call for Proposals (CFP) and the exciting RubyConf tracks planned for this year. As she details the structure of RubyConf, featuring three simultaneous tracks and a community-focused day, you'll see why this event is a must-attend for anyone in the Ruby community.Ever hit a roadblock while working on a project? Kinsey discusses common blockers at GitHub and how tools like Sorbet, AASM, and Packwork have transformed their workflow. With insights from experienced organizers like Spike from Rocky Mountain Ruby, you'll learn about the importance of having a playbook and support system in place. Finally, get inspired to submit your talk for upcoming conferences, leveraging coaching resources to ensure your proposals shine. Kinsey's enthusiasm and wealth of knowledge make this episode a treasure trove for anyone passionate about tech, community, and personal growth.Send us some love.HoneybadgerHoneybadger is an application health monitoring tool built by developers for developers.Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the Show.Ready to start your own podcast?This show is hosted on Buzzsprout and it's awesome, not to mention a Ruby on Rails application. Let Buzzsprout know we sent you and you'll get a $20 Amazon gift card if you sign up for a paid plan, and it helps support our show.

The Actiwatch is a popular actigraphy device that is no longer sold or supported by Philips. Its discontinuation coincided with the launch of the AASM's “Act on Actigraphy” campaign, which highlights the importance of actigraphy testing for sleep disorders and urges payers to reimburse health care professionals for this medical service. Dr. Paul Raymond, vice chair of the AASM Coding and Reimbursement Advisory Committee, discusses reimbursement for actigraphy, its clinical use, and current and future options for device selection.

In this episode, we delve into the fascinating world of time changes and their effects on our daily lives. We're joined by Dr. karin Johnson to explore the immediate aftermath of clock changes, discussing the short-term disruptions to sleep patterns, mood, and productivity that accompany the abrupt shift. Then, we get into the long-term consequences of living under different time systems: permanent daylight saving time versus standard time. We examine the impacts on health, safety, and energy consumption, considering both the physiological and societal implications.   About Dr. Karin Johnson Dr. Karin Johnson, MD, FAAN, FAASM is professor of Neurology at UMass Chan School of Medicine-Baystate and Medical Director of Baystate Health Regional Sleep Program in Springfield MA. She is vice president of Save Standard Time, a volunteer run nonprofit advocating for permanent standard time.  She is co-chair of the Coalition for Permanent Standard Time Coalition and a member of the AASM advocacy committee and sleep section chair of the American Academy of Neurology. She hosted the Science of Clock Change educational video series.   About Meghna Dassani Dr. Meghna Dassani is passionate about promoting healthy sleep through dental practices. In following the ADA's 2017 guideline on sleep apnea screening and treatment, she has helped many children and adults improve their sleep, their breathing, and their lives. Her books and seminars help parents and practitioners understand the essential roles of the tongue, palate, and jaw in promoting healthy sleep.   Connect with Dr. Meghna Dassani Website: https://www.meghnadassani.com Facebook: https://www.facebook.com/healthysleeprevolution Instagram: https://www.instagram.com/healthysleeprevolution/ Youtube: https://www.youtube.com/channel/UC9Lh_n7xmbhQVPGQrSjBIrw Get a copy of Airway is Life: https://www.airwayislife.com  

According to the Academy of Sleep Medicine (AASM), the Sleep Research Society (SRS), and the National Sleep Foundation (NSF), adults should regularly sleep at least 7 hours a night to promote optimal health. However, over one-quarter of adults do not meet this recommendation. (Oops, me included!) AASM states that about 30% of adults have insomnia symptoms, and about 10% of adults have insomnia that is severe enough to cause daytime repercussions. What is it about sleep that it's so important to have? What is the parameter of good and quality sleep? What are the health risks of not sleeping enough? In this episode, we tackle it all: sleep, dreams, the sleep cycle, sleeping pills, sleep disorders, and so much more!We are joined today by Dr. Meredith Broderick, a triple-board certified sleep neurologist and the Founder of Sound Sleep Guru, a boutique sleep telehealth service focused on discovering the root of individualized sleep problems. She received her BA in Chemistry from The Ohio State University as Summa Cum Laude​, MD from The Ohio State University College of Medicine, Neurology Residency at the University Hospitals of Cleveland, and Sleep Disorders and Behavioral Sleep Medicine Fellowship at Stanford University. Dr. Broderick is on the Medical Advisory Board of Ozlo Sleepbuds®, wireless biometric sensors to help optimize the sleeping experience. She has been the Assistant Professor of Neurology at Case Western Reserve School of Medicine, the Sleep Lab Director at Alaska Neurology Center, and the Medical Director at several sleep centers in Seattle, Washington.Livestream Air Date: June 28, 2023Follow Meredith Broderick, MD: InstagramFollow Friends of Franz Podcast: Website, Instagram, FacebookFollow Christian Franz Bulacan (Host): Instagram, YouTubeThankful to the season's brand partners: Covry, House of M Beauty, Nguyen Coffee Supply, V Coterie, Skin By Anthos, Halmi, By Dr Mom, LOUPN, Baisun Candle Co., RĒJINS, Twrl Milk Tea, 1587 Sneakers

Dr. Anita Shelgicar of AASM, and a Neurology Professor at the U of M says it's absolutely time to keep us on Standard Time as "Spring Forward" can be very bad for us

Cameron Diaz thinks people “should normalize separate bedrooms” for couples. Turns out, the actress isn't alone. In a perfect world, Diaz said she'd have it this way: “I have my house, you have yours. We have the family house in the middle. I will go and sleep in my room. You go sleep in your room.” What is sleep divorce?Whether it's due to snoring, tossing and turning or stealing the covers, a study published in July found that over a third of Americans agree with Diaz when it comes to so-called “sleep divorces.”The American Academy of Sleep Medicine survey shows that more than one-third of people say they occasionally or consistently sleep in another room to accommodate their partner.45% of men reported they occasionally or consistently sleep in a different room, compared with just 25% of women.“Although the term ‘sleep divorce' seems harsh, it really just means that people are prioritizing sleep and moving into a separate room at night when needed,” Dr. Seema Khosla, pulmonologist and spokesperson for the AASM, said in a news release. --- Support this podcast: https://podcasters.spotify.com/pod/show/thecoffeebreakup/support

The AASM released an update to the scoring manual earlier this year. Some of the changes were minor and others more significant. Adhering to the AASM scoring manual is a mandate of accreditation. Dr. Matt Troester, Dr. Alcibiades Rodriguez and Dr. Rich Berry are here to review these changes and highlight the most clinically pertinent information from the latest iteration of the scoring manual version 3.

Dr. Anne-Marie Morse of the AASM discusses the increased health benefits to "Fall Back" and keep us on Standard Time

A few years ago, the AASM held a competition challenging us to reimagine sleep care. The Mobile Sleep Lab was a model that was submitted as a contender in this challenge. Here to tell us more about this are Dr. Mark Boulos, Dr. Luqi Chi and Dr. Oleg Chernyshev.

The SleepTech Talk crew talks to Joe Anderson this week. Joe is an OG in sleep, with the original Sleep Tech Podcast. Joe has such a full resume that it is hard to put it all down here. He's currently the Director of Business Development and Education for Priority Health Education and the Clinical Manager for Sleep, EEG, Wound Care, and Hyperbaric Medicine at Sovah Health. He is also a former committee member of the AASM and the BRPT. Listen in as Joe tells us about his journey into sleep healthcare. And listen closely as he gives listeners a priority one discount on CEUs! Don't forget to Like, Share, and Subscribe!  Credits: Audio/ Video: Diego R Mann; Music: Pierce G Mann  Hosts: J. Emerson Kerr, Robert Miller, Gerald George Mannikarote  Copyright: ⓒ 2023 SleepTech Talk Productions

The AASM recently released a new clinical practice guideline which provides necessary recommendations for adults with REM Sleep Behavior disorder. The guideline provides clinicians with insight on how best to prevent sleep-related injury and how to provide patients with a risk assessment for neurological disease. Here to tell us more about this is Dr. Michael Howell.    

David E McCarty MD FAASM attended medical school at Duke University, and completed an internship and residency in Internal Medicine in Boston, at Massachusetts General Hospital. He began his career practising primary care, but after a handful of years in practice, he followed his own white rabbit into a whole new world called Sleep Medicine. Dr McCarty learned the art from the great Dr Andrew Chesson (world-class physician, and past president of the AASM). While at LSU, Dr McCarty won some teaching awards, published a few papers, and it's also where he developed the Five Finger Approach, which has remained the cornerstone of his teaching about patient-centred problem-solving, to this day, and is featured as the pinnacle for orienteering around the Isle. In addition to patient care and academic endeavours, Dr McCarty has had plenty of experience as a public speaker at regional and national meetings throughout his career.He retired from the practice of clinical medicine in 2021, to devote his energy to patient education.   ----    Shownotes are available at Dr Dave McCarty: Why You Need an Empowered Approach to Sleep and Insomnia   ----    Join the Unstress Health Community & Transform Your Life! https://bit.ly/3SRq0gg    Connect with Dr Ron at Unstress Health  Instagram: https://www.instagram.com/unstresshealth/  Facebook: https://fb.me/unstresshealth  Email: admin@unstresshealth.com   DISCLAIMER: This podcast provides general information and discussion about medicine, health and related subjects. This content is not intended and should not be construed as medical advice or as a substitute for care by a qualified medical practitioner. If you or any other person has a medical concern, he or she should consult with an appropriately qualified medical practitioner. Guests who speak in this podcast express their own opinions, experiences and conclusions. See omnystudio.com/listener for privacy information.

In today's episode of Talking Sleep, we discuss the use of melatonin in both children and adults. Our guests Dr. Abby Strang and Dr. Gautam Ganguly, talk about the AASM's recent health advisory for the appropriate use of melatonin in children and the importance of understanding how melatonin works. Listen now

Have you tried all the tips and hacks on Youtube to get rid of your chronic fatigue, with only some results? Are you too tired to focus on your work or to be present for your family members?  In this video, I'll reveal one condition that almost no one on this platform talks about, not even the experts. Stick to the end, and I'll give you 5 simple tips to finally have the energy to be more productive at work, school, or to enjoy life again. ✅ Timeline 00:00  Introduction 01:09   Common YouTube recommendations 02:32   The problem with sleep apnea 04:57   Coverage criteria for mild sleep apnea 05:25   Upper airway resistance syndrome (UARS) 06:04   Sleep endoscopy in UARS 07:15    Smaller jaws, smaller airways 08:04.  Five simple tips to get you started 08:09   1. Shut your mouth and breathe through your nose 09:08   2. Avoid eating or snacking within 3-4 hours of bedtime 09:36   3. Find your best sleep position 09:28   4. Avoid all screens before bedtime 09:49   5. Prioritize your sleep length 10:04    Energize Your Day Starter Guide PDF 10:44   90-Day Sleep Diet Course ✅ LINKS MENTIONED Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women.  AASM clarifies hypopnea scoring criteria.  Why Zebras Don't Get Ulcers by Robert Sapolsky.  Sleep, Interrupted: A Physician Reveals The #1 Reason Why So Many Of Us Are Sick And Tired.  7 Long-Lasting Ways to Clear Your Stuffy Nose – ENT Doctor Approved.  Should You Tape Your Mouth For Better Sleep?  Energize Your Day Starter Guide. The 90 Day Sleep Diet. Lose Weight Naturally Without Cardio Or Calorie Counting.  ✅ PRODUCTS & SERVICES How you can lose weight naturally without cardio or counting calories. Dr. Park's The 90-Day Sleep Diet.  Want to un-stuff your stuffy nose? Read the e-book, How to Un-stuff Your Stuffy Nose: Breathe Better, Lose Weight, Sleep Great (PDF)  Your Health Transformation Workbook: Refresh, Restore, & Rejuvenate Your Life (online format)  Want to have more energy, sleep better, have less pain, and enjoy living again? Reserve a Virtual Coaching session today with Dr. Park  ✅ CONNECT WITH DR. PARK DoctorStevenPark.com doctorpark@doctorstevenpark.com For inquiries about interviews or presentations, please contact Dr. Park through his website at doctorstevenpark.com. ✅ DISCLAIMER This video is for general educational and informational purposes only. It is not to be taken as a substitute for professional medical advice, diagnosis, or treatment. Please consult with your doctor first before making any changes to your health, exercise, nutrition, or dietary regimen. Certain product links above will take you to Amazon.com. If you then go on to buy the product, Amazon will provide me with a small commission, which will not cost you anything.      

Jennifer L. Martin, PhD, became president of the American Academy of Sleep Medicine (AASM) board of directors on June 6, 2022. She speaks with Sleep Review about the challenges faced by people with insomnia disorder in accessing cognitive behavioral therapy for insomnia (CBT-I) and pharmaceuticals to treat the sleep disorder, as well as posits several solutions. Sree Roy of Sleep Review and Martin discuss:-What is a psychologist's role in sleep medicine?-How is the AASM collaborating with other stakeholders to identify and prioritize strategies to increase access to high-quality care for insomnia disorder?-How can sleep medicine overcome reimbursement challenges when it comes to insomnia?-Other goals for her 1-year AASM presidency term

In today's episode of Talking Sleep, we discuss safe and effective CPAP use in pediatric patients with obstructive sleep apnea. Drs. Louella Amos and Robin Lloyd join us to share information about the AASM's recent position statement on age and weight requirements for PAP therapy in pediatric patients and the importance of appropriate management of younger, smaller children.

In this episode of Talking Sleep, we highlight what to expect if your sleep practice is selected for a Medicare audit. AASM Coding and Compliance Committee Vice Chair Dr. Gabriela de Bruin discusses what auditors are often looking for, how to be prepared for an audit, the benefits of implementing a compliance program, and AASM resources available to help you.

In this months episode we discuss narcolepsy with Matthew Horsnell. Matt is a narcolepsy patient and advocate, and we discuss his journey of living with narcolepsy. SHOW NOTES Introduction of Guest: (5:00) Matt’s Best Advice (11:00) Matt’s Role in the sleep community (12:40) Matt’s symptoms onset (15:00) Matt’s additional symptoms (19:00) Matt’s onset of cataplexy (23:00) Cataplexy triggers (24:45) Delayed diagnosis: (27:00) Nightmares and sleep paralysis onset (31:30) One more question about sleep paralysis (34:15) Partial cataplexy (37:50) Diagnosis and Management: (39:00) Pitolisant (43:45) Strategic Napping (44:15) Bitter Pills (45:15) AASM revised Guidelines (47:22) Sodium Oxybate and Cataplexy (49:00) Finding a sleep physician to manage narcolepsy (55:00) Sleep apnea (60:30) MSLT (62:15) Treat Clinically (65:00) 4 pillars of management (66:00) Patient request/feedback (68:00) Academic vs private practice (71:30) Links to articles and guidelines referenced in this episode are included Trotti LM. Central Disorders of Hypersomnolence. Continuum (Minneap Minn). 2020 Aug;26(4):890-907. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline

In this months episode we discuss narcolepsy with Matthew Horsnell. Matt is a narcolepsy patient and advocate, and we discuss his journey of living with narcolepsy. SHOW NOTES Introduction of Guest: (5:00) Matt’s Best Advice (11:00) Matt’s Role in the sleep community (12:40) Matt’s symptoms onset (15:00) Matt’s additional symptoms (19:00) Matt’s onset of cataplexy (23:00) Cataplexy triggers (24:45) Delayed diagnosis: (27:00) Nightmares and sleep paralysis onset (31:30) One more question about sleep paralysis (34:15) Partial cataplexy (37:50) Diagnosis and Management: (39:00) Pitolisant (43:45) Strategic Napping (44:15) Bitter Pills (45:15) AASM revised Guidelines (47:22) Sodium Oxybate and Cataplexy (49:00) Finding a sleep physician to manage narcolepsy (55:00) Sleep apnea (60:30) MSLT (62:15) Treat Clinically (65:00) 4 pillars of management (66:00) Patient request/feedback (68:00) Academic vs private practice (71:30) Links to articles and guidelines referenced in this episode are included Trotti LM. Central Disorders of Hypersomnolence. Continuum (Minneap Minn). 2020 Aug;26(4):890-907. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline

In this episode of Talking Sleep, we visit with Dr. Donna Arand and Dr. David Davila, members of the AASM task force that recently updated protocols for the Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT). The guidance provides detailed information on patient management, testing procedures, and reporting to ensure the tests provide high-quality, consistent data.

The SleepTech Talk Team discusses the accreditation process with Kimi Clark Vice Chair of the AASM Accreditation Committee. We also ask Kimi a few of the questions submitted by our listeners! SLEEPTECH TALK is available on APPLE, GOOGLE, and SPOTIFY podcast platforms. You can also find our YouTube channel at Link: https://www.youtube.com/channel/UC7Kia9qzghofBmGKAf7YEOg